Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sireesha V. Garimella"'
Publikováno v:
Breast Disease. 32:35-48
Breast cancer is the most frequently diagnosed cancer in women and one of the leading causes of cancer death for women. Worldwide, over 1.3 million cases of invasive breast cancer are diagnosed, and more than 450,000 women die from breast cancer annu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1fea10d5e3b448ddbaac32b0b6d3006
https://doi.org/10.3233/bd-2010-0307
https://doi.org/10.3233/bd-2010-0307
Autor:
Bernd Fischer, Sireesha V. Garimella, Rajnish P. Rao, Polani B. Seshagiri, Sarah Tonack, Nicole Ramin, Anne Navarrete Santos
Publikováno v:
Annals of Anatomy - Anatomischer Anzeiger. 191:485-495
During preimplantation development, embryos of many species are known to express up to five isoforms of the facilitative glucose transporter proteins (GLUT). Development of hamster blastocysts is inhibited by glucose. We therefore investigated GLUT i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bfcae42c6bd065c4fb322aaabeeb65a
https://doi.org/10.1016/j.aanat.2009.06.002
https://doi.org/10.1016/j.aanat.2009.06.002
Autor:
Kristie Gehlhaus, Natasha J. Caplen, Jason J. Pitt, Jennifer L Dine, Magdalena Grandin, Sirisha Chakka, Stanley Lipkowitz, Sireesha V. Garimella, Marion M. Nau
Publikováno v:
Breast Cancer Research : BCR
Introduction Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binds to its receptors, TRAIL-receptor 1 (TRAIL-R1) and TRAIL-receptor 2 (TRAIL-R2), leading to apoptosis by activation of caspase-8 and the downstream executioner caspases,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c85854459a48eefb0a5f879f1a7e9e8
https://doi.org/10.1186/bcr3645
https://doi.org/10.1186/bcr3645
Autor:
Natasha J. Caplen, Tamara L. Jones, Lyndsay M. Murrow, Stanley Lipkowitz, Sireesha V. Garimella
Publikováno v:
Breast cancer research and treatment. 122(2)
Breast cancers can be classified into those that express the estrogen (ER) and progesterone (PR) receptors, those with ERBB2 (HER-2/Neu) amplification, and those without expression of ER, PR, or amplification of ERBB2 (referred to as triple-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618f6793034730b4a427f1ebf3fe7803
https://pubmed.ncbi.nlm.nih.gov/19821025
https://pubmed.ncbi.nlm.nih.gov/19821025
Autor:
Kristie Gehlhaus, Jennifer L Dine, Natasha J. Caplen, Magda Grandin, Daniel Letwin, Sireesha V. Garimella, Stanley Lipkowitz
Publikováno v:
Cancer Research. 75:15-15
TNF-related apoptosis inducing ligand (TRAIL) selectively induces apoptosis in transformed cells by activating the extrinsic apoptotic pathway via its cognate receptors on the cell surface, TRAIL receptor 1 and TRAIL receptor 2. Triple negative breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2791fd39b7b4d0a1c752da3297d45e21
https://doi.org/10.1158/1538-7445.am2015-15
https://doi.org/10.1158/1538-7445.am2015-15
Autor:
Natasha J. Caplen, Magda Grandin, Stanley Lipkowitz, Sireesha V. Garimella, Jennifer L Dine, Kristie Gehlhaus
Publikováno v:
Cancer Research. 74:5124-5124
TNF-related apoptosis inducing ligand (TRAIL) is a member of the tumor necrosis factor super family and can induce apoptotic cell death upon binding to its cognate receptors, TRAIL Receptor 1 (TRAIL-R1) and TRAIL Receptor 2 (TRAIL-R2). TRAIL has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9f0a1d515c366f00537583d70dfa4bb
https://doi.org/10.1158/1538-7445.am2014-5124
https://doi.org/10.1158/1538-7445.am2014-5124
Publikováno v:
Cancer Research. 71:4106-4106
Tumor Necrosis Factor (TNF)-Related Apoptosis Inducing Ligand (TRAIL) is a member of the TNF family. The ligand binds to its receptors TRAIL-R1 or TRAIL-R2 leading to formation of the death-inducing signaling complex (DISC) which cleaves the initiato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27de041ed0985bca96da48d44d552486
https://doi.org/10.1158/1538-7445.am2011-4106
https://doi.org/10.1158/1538-7445.am2011-4106